Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Confluent (CFLT) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Confluent (CFLT) over the last 6 years, with Q3 2025 value amounting to $298.5 million.

  • Confluent's Cash & Equivalents fell 746.08% to $298.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $298.5 million, marking a year-over-year decrease of 746.08%. This contributed to the annual value of $386.0 million for FY2024, which is 1035.54% up from last year.
  • According to the latest figures from Q3 2025, Confluent's Cash & Equivalents is $298.5 million, which was down 746.08% from $295.6 million recorded in Q2 2025.
  • Confluent's 5-year Cash & Equivalents high stood at $1.4 billion for Q4 2021, and its period low was $44.1 million during Q1 2021.
  • For the 5-year period, Confluent's Cash & Equivalents averaged around $470.1 million, with its median value being $343.5 million (2023).
  • Its Cash & Equivalents has fluctuated over the past 5 years, first skyrocketed by 364006.36% in 2021, then plummeted by 6832.83% in 2022.
  • Confluent's Cash & Equivalents (Quarter) stood at $1.4 billion in 2021, then tumbled by 68.33% to $435.8 million in 2022, then fell by 19.74% to $349.8 million in 2023, then increased by 10.36% to $386.0 million in 2024, then fell by 22.65% to $298.5 million in 2025.
  • Its Cash & Equivalents was $298.5 million in Q3 2025, compared to $295.6 million in Q2 2025 and $278.6 million in Q1 2025.